Home/IR-Med/Aharon Binur

AB

Aharon Binur

Chief Development Officer

Therapeutic Areas

Wound Care Diabetes Infectious Disease Pharmacology

IR-Med Pipeline

Drug	Indication	Phase
PressureSafe	Pressure Injury Detection	preclinical
DiaSafe	Diabetic Foot Ulcer Detection	preclinical
NoBiotics	Pediatric Ear Infection (Viral vs Bacterial) Detection	preclinical
Drug Monitor	Therapeutic Drug Monitoring	preclinical

Leadership Team at IR-Med

Sharon Levkoviz

Chief Financial Officer

Dr. Yaniv Cohen

Co-Founder & Chief Science Officer

Head of Software & AI

VP Business Development

View full IR-Med profile